Drug Search Results
More Filters [+]

Terutroban

Alternative Names: terutroban
Latest Update: 2021-11-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: TXA2 Antagonist

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Institut de Recherches Internationales Servier
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Terutroban

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Stroke

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

PERFORM

P3

Completed

Stroke

2010-01-27

2007-000176-17

P2

Completed

Stroke

2009-04-20

Recent News Events